FDA label
What is Mydayis used for?
Mydayis contains dextroamphetamine and amphetamine. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “MYDAYIS is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 13 years and older.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Mydayis?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Mydayis, capsule, extended release
Indications and Usage, quoted from the label by Takeda Pharmaceuticals America, Inc. (NDA022063). Cross-references to other label sections are left out.
MYDAYIS is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 13 years and older.
Limitations of Use:
Pediatric patients 12 years and younger experienced higher plasma exposure than patients 13 years and older at the same dose, and experienced higher rates of adverse reactions, mainly insomnia and decreased appetite.
Source: DailyMed label, set id 141a7970-3f06-44ea-9ab7-aeece2c085fc, version 13, effective April 30, 2026. NDC 54092-468, one of 4 listings for this product.
Questions
What is Mydayis used for?
The FDA label says: “MYDAYIS is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 13 years and older.”
What drug class is Mydayis?
FDA lists dextroamphetamine and amphetamine in the Central Nervous System Stimulant established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Mydayis
- Is Mydayis a controlled substance?Schedule II
- Generic for MydayisFDA Orange Book
- What is Dextroamphetamine and Amphetamine used for?FDA label uses
- Is Dextroamphetamine and Amphetamine a controlled substance?Schedule II
- Generic for Adderall XRFDA Orange Book
- Generic for AdderallFDA Orange Book
- Central Nervous System Stimulants listFDA drug class
- NDC 54092-468Mydayis NDC record
- NDC 54092-471Mydayis NDC record
- NDC 54092-474Mydayis NDC record
- Schedule II drugs listDEA schedule